Related Experiment Video
Updated: May 30, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Joint protection in haemophilia
E C Rodriguez-Merchan1, V Jimenez-Yuste, J A Aznar
1Department of Orthopaedic Surgery, La Paz University Hospital, Madrid, Spain and School of Medicine, Autonomous University, Madrid, Spain. ecrmerchan@gmx.es
Early diagnosis and intensive treatment are crucial for managing haemarthroses (intra-articular haemorrhages) in haemophilia patients. Prophylaxis is the most effective preventative strategy, minimizing joint bleeds and preventing long-term arthropathy.
Area of Science:
- Hematology
- Orthopedics
- Radiology
Background:
- Haemarthroses (intra-articular haemorrhages) are common in haemophilia patients.
- Prompt diagnosis and intensive treatment are essential to prevent joint degeneration (haemophilic arthropathy).
- Subclinical bleeds can also contribute to arthropathy, particularly in ankles.
Purpose of the Study:
- To review the diagnosis and management of haemarthroses in haemophilia.
- To highlight the importance of early and intensive treatment strategies.
- To discuss prophylactic measures and treatment options for inhibitor patients.
Main Methods:
- Review of current diagnostic techniques, including ultrasonography (US) and magnetic resonance imaging (MRI).
- Discussion of treatment modalities such as joint aspiration, enhanced on-demand treatment, and prophylaxis.
- Exploration of management strategies for patients with inhibitors, including bypassing agents and immune tolerance induction (ITI).
Main Results:
- Early diagnosis and intensive treatment, including joint aspiration for profuse bleeds, are vital.
- Primary prophylaxis is the most effective method to prevent haemarthrosis and subsequent arthropathy.
- Secondary prophylaxis and enhanced on-demand treatment are alternatives when primary prophylaxis is not feasible.
Conclusions:
- Effective management of haemarthroses requires a multi-faceted approach, prioritizing prophylaxis.
- Treatment strategies must be tailored to individual patient needs, including those with inhibitors.
- Minimizing bleeding episodes is key to preserving joint function and preventing long-term complications in haemophilia.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
